215 related articles for article (PubMed ID: 671775)
1. [Prevalence of inhibitors in hemophiliacs with reference to the transfusion of blood products (author's transl)].
Kamiya T
Rinsho Byori; 1978; 26(4):291-7. PubMed ID: 671775
[No Abstract] [Full Text] [Related]
2. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
Schimpf K; Schwarz P; Kunschak M
Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
[No Abstract] [Full Text] [Related]
3. [Treatment of hemophiliacs with inhibitors].
Fujimaki M
Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
[No Abstract] [Full Text] [Related]
4. A simple inhibitor screen is more sensitive than a Bethesda assay in monitoring for the development of inhibitors in haemophilia A and B.
Keeling D; Beavis J; Sukhu K
Br J Haematol; 2005 Mar; 128(6):885. PubMed ID: 15755295
[No Abstract] [Full Text] [Related]
5. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
Nilsson IM; Berntorp E
Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
[No Abstract] [Full Text] [Related]
6. Transfusion support for haemophiliacs.
Allain JP
Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
[No Abstract] [Full Text] [Related]
7. [Prospective matched control study concerning the treatment and quality of life of hemophiliacs with inhibitors].
Honda K; Nagao T; Kamiya T; Yoshioka A; Miyazaki T; Takeda T; Mori K; Fukutake K; Hanabusa H; Taki M; Mohri H; Miyama J; Takamatsu J; Kinoshita S; Shirahata A
Rinsho Ketsueki; 1998 Jun; 39(6):416-21. PubMed ID: 9695668
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of inhibitors in a population of 3435 hemophilia patients in France. French Hemophilia Study Group.
Sultan Y
Thromb Haemost; 1992 Jun; 67(6):600-2. PubMed ID: 1509398
[TBL] [Abstract][Full Text] [Related]
9. [The occurrence of immunological tolerance to inhibitors of factors VIII and IX in hemophilia patients].
Brakman GG
Gematol Transfuziol; 1993 Feb; 38(2):18-20. PubMed ID: 8020714
[TBL] [Abstract][Full Text] [Related]
10. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
11. Inhibitors in young boys with haemophilia.
Lusher JM
Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
[TBL] [Abstract][Full Text] [Related]
12. [Factor VIII inhibitor in multitransfused hemophiliacs. A finding of varying therapeutic consequences].
Ly B; Evensen SA; Stavem P
Tidsskr Nor Laegeforen; 1977 Apr; 97(12):554-6, 8. PubMed ID: 854906
[No Abstract] [Full Text] [Related]
13. Retrospective study of inhibitor formation in Japanese hemophiliacs.
Kamiya T; Takahashi I; Saito H
Int J Hematol; 1995 Oct; 62(3):175-81. PubMed ID: 8589362
[TBL] [Abstract][Full Text] [Related]
14. Factor VIII inhibitors in hemophilia.
Mariani G
Bilt Hematol Transfuz; 1979; 7(1):3-41. PubMed ID: 121880
[No Abstract] [Full Text] [Related]
15. Low prevalence of inhibitor antibodies in the Canadian haemophilia population.
Webert KE; Rivard GE; Teitel J; Carcao M; Lillicrap D; St-Louis J; Walker IR
Haemophilia; 2012 May; 18(3):e254-9. PubMed ID: 22077390
[TBL] [Abstract][Full Text] [Related]
16. New alternatives and strategies in the treatment of inhibitors.
Hoyer LW
Prog Clin Biol Res; 1984; 150():367-72. PubMed ID: 6431440
[TBL] [Abstract][Full Text] [Related]
17. [Hemophilia: pathophysiology, diagnosis and treatment (author's transl)].
Ito M
Nihon Naika Gakkai Zasshi; 1976 Jun; 65(6):543-59. PubMed ID: 789795
[No Abstract] [Full Text] [Related]
18. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
Mathias M; Khair K; Hann I; Liesner R
Br J Haematol; 2004 May; 125(3):366-8. PubMed ID: 15086418
[TBL] [Abstract][Full Text] [Related]
19. Modulation of allogeneic cytotoxic activity by factor VIII or IX concentrates.
Soria AG; Bouzas MB; Anselmo A; Ruibal-Ares BH
Haematologica; 1991; 76(1):33-7. PubMed ID: 1829058
[TBL] [Abstract][Full Text] [Related]
20. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital].
Diniz MJ; Dias Francisco F; Tavares ML; Leal I
Acta Med Port; 1992 Apr; 5(4):178-80. PubMed ID: 1605065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
